UBS’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$63K Buy
2,040
+328
+19% +$10.9K ﹤0.01% 6543
2014
Q2
$62K Sell
1,712
-12,492
-88% -$404K ﹤0.01% 6581
2014
Q1
$429K Sell
14,204
-363
-2% -$8.37K ﹤0.01% 4394
2013
Q4
$333K Buy
14,567
+13,475
+1,234% +$282K ﹤0.01% 4753
2013
Q3
$22K Sell
1,092
-52,544
-98% -$1.28M ﹤0.01% 7944
2013
Q2
$1.44M Buy
+53,636
New +$1.61M ﹤0.01% 2906

Other funds holding OFIX

UBS's OFIX Position: Q3 2014 in Review

UBS increased its Orthofix Medical (OFIX) stake by 19% in Q3 2014, buying an estimated $10.9K and bringing the position to 2,040 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #6543.

UBS first reported a position in OFIX in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.44M in Q2 2013. 107 funds tracked by Wall St. Rank hold OFIX as of Q3 2014.

  • UBS held 2,040 shares of Orthofix Medical worth $63K as of Q3 2014.
  • UBS bought 328 Orthofix Medical shares in Q3 2014, an estimated $10.9K.
  • Orthofix Medical made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6543 holding.
  • UBS first reported a position in Orthofix Medical in Q2 2013 and has held it in 6 quarters since.
  • UBS's Orthofix Medical position peaked at $1.44M in Q2 2013.
  • 107 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.